Real-time enrollment status for this alpha-1 antitrypsin deficiency (aatd) clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 12:56 AM UTC
| NCT Number | NCT07227207 |
| Recruiting Status | Recruiting |
| Condition | Alpha-1 Antitrypsin Deficiency (AATD) |
| Phase | PHASE1 |
| Target Enrollment | 72 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Tessera Therapeutics, Inc. |
| Last Updated on CT.gov | August 21, 2026 (1 week ago) |
As of August 29, 2026: Clinical trial NCT07227207 is currently recruiting participants. This phase1 study for alpha-1 antitrypsin deficiency (aatd) is actively seeking new participants at 3 locations across the United States. The study is sponsored by Tessera Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07227207 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07227207 was last updated 1 week ago (August 21, 2026). HelloStudys verifies this status automatically.